OPKO Health Operating Income 2010-2024 | OPK
OPKO Health operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| OPKO Health Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $-152 |
| 2023 | $-157 |
| 2022 | $-226 |
| 2021 | $19 |
| 2020 | $58 |
| 2019 | $-274 |
| 2018 | $-171 |
| 2017 | $-276 |
| 2016 | $-97 |
| 2015 | $-98 |
| 2014 | $-146 |
| 2013 | $-80 |
| 2012 | $-37 |
| 2011 | $-23 |
| 2010 | $-11 |
| 2009 | $-22 |
| OPKO Health Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-33 |
| 2024-09-30 | $14 |
| 2024-06-30 | $-62 |
| 2024-03-31 | $-71 |
| 2023-12-31 | $-69 |
| 2023-09-30 | $-64 |
| 2023-06-30 | $7 |
| 2023-03-31 | $-31 |
| 2022-12-31 | $-55 |
| 2022-09-30 | $-88 |
| 2022-06-30 | $-11 |
| 2022-03-31 | $-72 |
| 2021-12-31 | $-63 |
| 2021-09-30 | $38 |
| 2021-06-30 | $6 |
| 2021-03-31 | $38 |
| 2020-12-31 | $49 |
| 2020-09-30 | $22 |
| 2020-06-30 | $27 |
| 2020-03-31 | $-41 |
| 2019-12-31 | $-112 |
| 2019-09-30 | $-39 |
| 2019-06-30 | $-47 |
| 2019-03-31 | $-75 |
| 2018-12-31 | $-90 |
| 2018-09-30 | $-33 |
| 2018-06-30 | $-5 |
| 2018-03-31 | $-43 |
| 2017-12-31 | $-158 |
| 2017-09-30 | $-48 |
| 2017-06-30 | $-26 |
| 2017-03-31 | $-45 |
| 2016-12-31 | $-74 |
| 2016-09-30 | $-24 |
| 2016-06-30 | $28 |
| 2016-03-31 | $-28 |
| 2015-12-31 | $-8 |
| 2015-09-30 | $-8 |
| 2015-06-30 | $-25 |
| 2015-03-31 | $-57 |
| 2014-12-31 | $-32 |
| 2014-09-30 | $-48 |
| 2014-06-30 | $-35 |
| 2014-03-31 | $-30 |
| 2013-12-31 | $-36 |
| 2013-09-30 | $-19 |
| 2013-06-30 | $-18 |
| 2013-03-31 | $-7 |
| 2012-12-31 | $-10 |
| 2012-09-30 | $-9 |
| 2012-06-30 | $-9 |
| 2012-03-31 | $-9 |
| 2011-12-31 | $-8 |
| 2011-09-30 | $-6 |
| 2011-06-30 | $-5 |
| 2011-03-31 | $-4 |
| 2010-12-31 | $3 |
| 2010-09-30 | $-4 |
| 2010-06-30 | $-6 |
| 2010-03-31 | $-4 |
| 2009-12-31 | $-2 |
| 2009-09-30 | $-6 |
| 2009-06-30 | $-5 |
| 2009-03-31 | $-9 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.055B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $200.815B | 87.96 |
| Thermo Fisher Scientific (TMO) | United States | $152.859B | 18.49 |
| Edwards Lifesciences (EW) | United States | $45.098B | 29.57 |
| Alcon (ALC) | Switzerland | $43.243B | 29.22 |
| IDEXX Laboratories (IDXX) | United States | $41.175B | 47.32 |
| DexCom (DXCM) | United States | $33.592B | 51.92 |
| IQVIA Holdings (IQV) | United States | $24.294B | 13.61 |
| STERIS (STE) | Ireland | $24.256B | 26.75 |
| Mettler-Toledo (MTD) | United States | $23.762B | 28.26 |
| Waters (WAT) | United States | $20.923B | 29.52 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.641B | 0.00 |
| Hologic (HOLX) | United States | $12.421B | 13.50 |
| Sysmex ADR (SSMXY) | Japan | $10.695B | 30.34 |
| Penumbra (PEN) | United States | $10.662B | 83.68 |
| Masimo (MASI) | United States | $8.371B | 30.88 |
| Globus Medical (GMED) | United States | $7.953B | 18.65 |
| Teleflex (TFX) | United States | $5.589B | 9.23 |
| Glaukos (GKOS) | United States | $5.235B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.155B | 21.77 |
| TransMedics (TMDX) | United States | $4.120B | 89.57 |
| PROCEPT BioRobotics (PRCT) | United States | $3.215B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.389B | 14.23 |
| Veracyte (VCYT) | United States | $2.231B | 31.31 |
| Nihon Kohden (NHNKY) | Japan | $2.102B | 24.11 |
| Elekta AB (EKTAY) | Sweden | $2.048B | 18.41 |
| Alphatec Holdings (ATEC) | United States | $1.862B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.512B | 0.00 |
| Artivion (AORT) | United States | $1.237B | 115.88 |
| Pulse Biosciences (PLSE) | United States | $1.109B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.011B | 5.38 |
| SiBone (SIBN) | United States | $0.805B | 0.00 |
| IRadimed (IRMD) | United States | $0.685B | 34.75 |
| Mesa Laboratories (MLAB) | United States | $0.659B | 14.41 |
| Beta Bionics (BBNX) | United States | $0.597B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.590B | 9.17 |
| NeuroPace (NPCE) | United States | $0.560B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.559B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.555B | 0.00 |
| RxSight (RXST) | United States | $0.541B | 0.00 |
| AxoGen (AXGN) | United States | $0.537B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.476B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.425B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.372B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.362B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.355B | 9.43 |
| Pacific Biosciences Of California (PACB) | United States | $0.318B | 0.00 |
| Neuronetics (STIM) | United States | $0.283B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.224B | 13.59 |
| Alpha Tau Medical (DRTS) | Israel | $0.208B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| Accuray (ARAY) | United States | $0.164B | 0.00 |
| 908 Devices (MASS) | United States | $0.162B | 0.00 |
| CVRx (CVRX) | United States | $0.161B | 0.00 |
| Inogen (INGN) | United States | $0.155B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.143B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.141B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.134B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.133B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.127B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.097B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 46.60 |
| InspireMD (NSPR) | Israel | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.062B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.058B | 0.00 |
| Hyperfine (HYPR) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.035B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.23 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |